Posts | Health Technology Assessment Division

Revised HTAC Preliminary Recommendation on the Inclusion of Insulin Glargine and the Non-Inclusion of Insulin Detemir in the PNF

Posted on August 23, 2022

Link to appeals form here: Topic Nomination (stakeholders may submit appeals to hta@doh.gov.ph until 07 September 2022.) Document Preview:

Evidence brief for 13 to 19 August 2022

Posted on August 22, 2022

For the period of 13 August 2022 to 19 August 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 13 to 19 August 2022

Evidence brief for 06 to 12 August 2022

Posted on August 15, 2022

For the period of 06 August 2021 to 12 August 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 06 to 12 August 2022

Evidence brief for 30 July to 05 August 2022

Posted on August 9, 2022

For the period of 30 July 2022 to 05 August 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 30 July to 05 August 2022

[Department Circular No. 2022- 0400] Change in the Generic Name of “Nicotine Polacrilex Medicated Chewing Gum” in the Philippine National Formulary (PNF) to “Nicotine”

Posted on August 4, 2022